CMND and SPRC Related Headlines

Go Back

Aug 24, 2026 08:51AM SciSparc unit files U.S. patent for MDMA-PEA combination for PTSD
Aug 24, 2026 08:51AM SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Mar 13, 2026 07:46AM Clearmind Medicine files Hong Kong patent for depression therapy combo
Mar 13, 2026 07:45AM Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
Mar 10, 2026 08:59AM Clearmind Medicine receives international patent for weight loss therapy
Mar 10, 2026 08:59AM Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Nov 20, 2025 06:45AM SciSparc files Israeli patent for depression treatment combination therapy
Nov 20, 2025 06:42AM SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Nov 17, 2025 07:55AM Clearmind Medicine files Israeli patent for depression treatment
Nov 17, 2025 07:55AM Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Oct 20, 2025 07:42AM SciSparc and Clearmind publish patent application for binge disorders
Oct 20, 2025 07:41AM SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
Oct 20, 2025 07:41AM Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

CMND and SPRC Related Press Releases

Go Back

Aug 24, 2026 08:51AM SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Mar 13, 2026 07:45AM Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
Mar 10, 2026 08:59AM Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Nov 20, 2025 06:42AM SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Nov 17, 2025 07:55AM Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Oct 20, 2025 07:41AM SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
Oct 20, 2025 07:41AM Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

CMND and SPRC Related SEC Filings

Go Back